Verona Pharma
Founded Year
2005Stage
Acq - Pending | IPOMarket Cap
9.03BStock Price
106.31Revenue
$0000About Verona Pharma
Verona Pharma is a biopharmaceutical company focused on the development and commercialization of therapies for respiratory diseases. It focus is on treatments for chronic conditions such as COPD, asthma, and cystic fibrosis. It products aim to address medical needs in the respiratory domain. Verona Pharma was formerly known as Isis Resources. It was founded in 2005 and is based in London, United Kingdom.
Loading...
Loading...
Verona Pharma Patents
Verona Pharma has filed 24 patents.
The 3 most popular patent topics include:
- phenols
- pneumonia
- combination drugs
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/15/2024 | 3/18/2025 | Pharmaceutical industry, Lactams, Pneumonia, Phenols, Chemical processes | Grant |
Application Date | 11/15/2024 |
|---|---|
Grant Date | 3/18/2025 |
Title | |
Related Topics | Pharmaceutical industry, Lactams, Pneumonia, Phenols, Chemical processes |
Status | Grant |
Latest Verona Pharma News
Sep 5, 2025
05.09.2025 - 11:45:05 Financing Secured for Major Pharmaceutical Transaction The pharmaceutical sector is closely monitoring the impending acquisition of Verona Pharma by industry giant Merck & Co., a transaction valued at approximately $10 billion. Market activity indicates near-certainty regarding the deal’s completion, with Verona’s share price trading consistently near the agreed acquisition price in recent sessions. This stability suggests investors perceive minimal risk of the arrangement falling through. Merck has taken concrete steps to solidify the acquisition, successfully placing $6 billion in bonds late last week to secure the necessary financing. This decisive move underscores the company’s commitment to the transaction, which is anticipated to finalize in the fourth quarter of 2025. The agreed-upon terms set the purchase price at $107 per American Depositary Share (ADS) of Verona Pharma.
Verona Pharma Frequently Asked Questions (FAQ)
When was Verona Pharma founded?
Verona Pharma was founded in 2005.
Where is Verona Pharma's headquarters?
Verona Pharma's headquarters is located at 3 More London Riverside, London.
What is Verona Pharma's latest funding round?
Verona Pharma's latest funding round is Acq - Pending.
Who are the investors of Verona Pharma?
Investors of Verona Pharma include Merck, Access Biotechnology, Abingworth, Soleus Capital Management, Foresite Capital and 17 more.
Loading...
Loading...